The Control of Anti-Donor Immune Responses by Regulatory T Cells in Organ Transplant Patients

Transplantation Proceedings

Volumn 40, Issue 5, 2008, Pages 1249-1252

  Dijke, I E ^a   Weimar, W ^a   Baan, C C ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; CALCINEURIN INHIBITOR; CD28 ANTIGEN; CD4 ANTIGEN; CD40 LIGAND; CD8 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 RECEPTOR ALPHA; MESSENGER RNA; RAPAMYCIN; TRANSCRIPTION FACTOR FOXP3;

ACUTE GRAFT REJECTION; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHRONIC GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; ORGAN TRANSPLANTATION; PATIENT MONITORING; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ANTIGENS, CD; HUMANS; IMMUNOSUPPRESSION; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY; TISSUE DONORS; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION TOLERANCE;

EID: 45449118923     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.04.004     Document Type: Article

References (34)

1. Sakaguchi S., Sakaguchi N., Asano M., et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155 (1995) 1151
2. Hara M., Kingsley C.I., Niimi M., et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 166 (2001) 3789
3. Taylor P.A., Noelle R.J., and Blazar B.R. CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J Exp Med 193 (2001) 1311
4. Graca L., Cobbold S.P., and Waldmann H. Identification of regulatory T cells in tolerated allografts. J Exp Med 195 (2002) 1641
5. Sakaguchi S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22 (2004) 531
6. Kingsley C.I., Karim M., Bushell A.R., et al. CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J Immunol 168 (2002) 1080
7. McHugh R.S., Whitters M.J., Piccirillo C.A., et al. CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16 (2002) 311
8. Fontenot J.D., Gavin M.A., and Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4 (2003) 330
9. Hori S., Nomura T., and Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299 (2003) 1057
10. Paust S., Lu L., McCarty N., et al. Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease. Proc Natl Acad Sci U S A 101 (2004) 10398
11. Cederbom L., Hall H., and Ivars F. CD4+CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur J Immunol 30 (2000) 1538
12. Wood K.J., and Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 3 (2003) 199
13. Stephens L.A., Mottet C., Mason D., et al. Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur J Immunol 31 (2001) 1247
14. Baecher-Allan C., Brown J.A., Freeman G.J., et al. CD4+CD25high regulatory cells in human peripheral blood. J Immunol 167 (2001) 1245
15. Taams L.S., Vukmanovic-Stejic M., Smith J., et al. Antigen-specific T cell suppression by human CD4+CD25+ regulatory T cells. Eur J Immunol 32 (2002) 1621
16. Demirkiran A., Kok A., Kwekkeboom J., et al. Low circulating regulatory T-cell levels after acute rejection in liver transplantation. Liver Transpl 12 (2006) 277
17. Vlad G., Ho E.K., Vasilescu E.R., et al. Anti-CD25 treatment and FOXP3-positive regulatory T cells in heart transplantation. Transpl Immunol 18 (2007) 13
18. Dijke I.E., Caliskan K., Korevaar S.S., et al. FOXP3 mRNA expression analysis in the peripheral blood and allograft of heart transplant patients. Transpl Immunol 18 (2008) 250
19. Dijke I.E., Korevaar S.S., Balk A.H., et al. CD4+CD25brightFoxP3+ regulatory T cells of rejecting heart transplant patients have inferior immune regulatory functions. [abstract]. J Heart Lung Transplant 27 (2008) S105
20. Meloni F., Vitulo P., Bianco A.M., et al. Regulatory CD4+CD25+ T cells in the peripheral blood of lung transplant recipients: correlation with transplant outcome. Transplantation 77 (2004) 762
21. Louis S., Braudeau C., Giral M., et al. Contrasting CD25hiCD4+T cells/FOXP3 patterns in chronic rejection and operational drug-free tolerance. Transplantation 81 (2006) 398
22. Baan C.C., Velthuis J.H., van Gurp E.A., et al. Functional CD25(bright+) alloresponsive T cells in fully immunosuppressed renal allograft recipients. Clin Transplant 21 (2007) 63
23. Bestard O., Cruzado J.M., Mestre M., et al. Achieving donor-specific hyporesponsiveness is associated with FOXP3+ regulatory T cell recruitment in human renal allograft infiltrates. J Immunol 179 (2007) 4901
24. Velthuis J.H.L., Mol W.M., Weimar W., et al. CD4+ CD25bright+ regulatory T cells can mediate donor non-reactivity in long-term immunosuppressed kidney allograft patients. Am J Transplant 6 (2006) 2955
25. Akl A., Jones N.D., Rogers N., et al. An investigation to assess the potential of CD25(high)CD4(+) T cells to regulate responses to donor alloantigens in clinically stable renal transplant recipients. Transpl Int 21 (2008) 65
26. Game D.S., Hernandez-Fuentes M.P., Chaudhry A.N., et al. CD4+CD25+ regulatory T cells do not significantly contribute to direct pathway hyporesponsiveness in stable renal transplant patients. J Am Soc Nephrol 14 (2003) 1652
27. Salama A.D., Najafian N., Clarkson M.R., et al. Regulatory CD25+ T cells in human kidney transplant recipients. J Am Soc Nephrol 14 (2003) 1643
28. Braudeau C., Racape M., Giral M., et al. Variation in numbers of CD4(+)CD25(high)FOXP3(+) T cells with normal immuno-regulatory properties in long-term graft outcome. Transpl Int 20 (2007) 845
29. Liu Z., Tugulea S., Cortesini R., et al. Specific suppression of T helper alloreactivity by allo-MHC class l-restricted CD8+CD28- T cells. Int Immunol 10 (1998) 775
30. Scotto L., Naiyer A.J., Galluzzo S., et al. Overlap between molecular markers expressed by naturally occurring CD4+CD25+ regulatory T cells and antigen specific CD4+CD25+ and CD8+CD28- T suppressor cells. Hum Immunol 65 (2004) 1297
31. Ciubotariu R., Vasilescu R., Ho E., et al. Detection of T suppressor cells in patients with organ allografts. Hum Immunol 62 (2001) 15
32. Sindhi R., Manavalan J.S., Magill A., et al. Reduced immunosuppression in pediatric liver-intestine transplant recipients with CD8+CD28- T-suppressor cells. Hum Immunol 66 (2005) 252
33. Chang C.C., Ciubotariu R., Manavalan J.S., et al. Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat Immunol 3 (2002) 237
34. Demirkiran A., Hendrikx T.K., Baan C.C., et al. Impact of immunosuppressive drugs on CD4+CD25+FOXP3+ regulatory T cells: does in vitro evidence translate to the clinical setting?. Transplantation 85 (2008) 783